Consun Pharmaceutical Group Management
Management criteria checks 2/4
Consun Pharmaceutical Group's CEO is Meng An, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is CN¥16.76M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 1.83% of the company’s shares, worth €10.18M. The average tenure of the management team and the board of directors is 3.5 years and 3.5 years respectively.
Key information
Meng An
Chief executive officer
CN¥16.8m
Total compensation
| CEO salary percentage | 6.6% |
| CEO tenure | less than a year |
| CEO ownership | 1.8% |
| Management average tenure | 3.5yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | CN¥785m |
| Sep 30 2023 | n/a | n/a | CN¥759m |
| Jun 30 2023 | n/a | n/a | CN¥734m |
| Mar 31 2023 | n/a | n/a | CN¥708m |
| Dec 31 2022 | CN¥17m | CN¥1m | CN¥683m |
| Sep 30 2022 | n/a | n/a | CN¥660m |
| Jun 30 2022 | n/a | n/a | CN¥636m |
| Mar 31 2022 | n/a | n/a | CN¥613m |
| Dec 31 2021 | CN¥14m | CN¥670k | CN¥590m |
Compensation vs Market: Meng's total compensation ($USD2.31M) is above average for companies of similar size in the German market ($USD1.04M).
Compensation vs Earnings: Meng's compensation has increased by more than 20% in the past year.
CEO
Meng An (51 yo)
less than a year
Tenure
CN¥16,760,000
Compensation
Mr. Meng An serves as Executive Chairman of the Board at Consun Pharmaceutical Group Limited since July 9, 2021 and serves a sits Chief Executive Officer from January 17, 2024. Mr. An being the Chairman of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | less than a year | CN¥16.76m | 1.83% CN¥ 10.2m | |
| Chief Scientist & Executive Director | 3.5yrs | CN¥3.78m | no data | |
| Assistant GM | 3.2yrs | CN¥755.00k | no data | |
| CFO & VP | 4.2yrs | no data | no data | |
| Assistant President | 4.3yrs | no data | no data | |
| Board Secretary | 10.1yrs | no data | no data | |
| Company Secretary | 11.2yrs | no data | no data | |
| Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd | 3.5yrs | no data | no data | |
| Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd | 3.5yrs | no data | no data |
3.5yrs
Average Tenure
52.5yo
Average Age
Experienced Management: C1P's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 3.2yrs | CN¥16.76m | 1.83% CN¥ 10.2m | |
| Chief Scientist & Executive Director | 11.4yrs | CN¥3.78m | no data | |
| Assistant GM | 3.2yrs | CN¥755.00k | no data | |
| Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd | 3.5yrs | no data | no data | |
| Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd | 3.5yrs | no data | no data | |
| Independent Non-Executive Director | 10.4yrs | CN¥144.00k | no data | |
| Independent Non Executive Director | 5yrs | CN¥144.00k | no data | |
| Non-Executive Director | 2.8yrs | no data | no data |
3.5yrs
Average Tenure
48yo
Average Age
Experienced Board: C1P's board of directors are considered experienced (3.5 years average tenure).